Patents Assigned to Conn. / Teva Pharmaceuticals USA, Inc.
  • Patent number: 6017531
    Abstract: Hydrophillic compositions and methods of use are provided for debriding and wound healing applications. The compositions contain certain proteases produced by microorganisms of the genus Vibrio.
    Type: Grant
    Filed: June 2, 1997
    Date of Patent: January 25, 2000
    Assignees: W. R. Grace & Co., Conn. / Teva Pharmaceuticals USA, Inc.
    Inventors: Donald Zane Fortney, Donald Richard Durham, Kang Yang